Posts by DAY Vision
MarginProbe® is Very Effective in Preventing Repeat Breast Cancer Surgeries, Study Shows
[vc_row][vc_column][vc_column_text]Paoli, PA, Jan. 13, 2015 – Results of the study, MarginProbe device is able to reduce re-excision rate of breast conserving surgery in invasive and pre-invasive breast cancer independent from any patient or tumor-related factors, were presented as part of the general poster session at the recent San Antonio Breast Cancer Symposium (SABCS). The study,…
Read MoreThe Impact Use of an Intraoperative Margin Assessment Device on Re-Excision Rates
[vc_row][vc_column][vc_column_text] This study was originally published as an Open Access article in Springer Plus and has been recreated under the terms of the Creative Commons Attribution License. Molly Sebastian1*, Stephanie Akbari1 , Beth Anglin2 , Erin H Lin3 and Alice M Police3 (* Correspondence: [email protected] 1 Virginia Hospital Center, Reinsch Pierce Family Center for Breast Health,…
Read MoreDilon Devices Announces FDA Approval of Updated Version of MarginProbe® with Feature Enhancements, Further Improving User-Friendly Experience for Surgeons
[vc_row][vc_column][vc_column_text] Medical Device update offers brighter screen, reduced size and emphasized alerts to improve ease-of-use for surgeons Paoli, PA, Jan. 5, 2015 – Today, Dilon Devices announced FDA approval of an updated version of its flagship product, MarginProbe, a medical device that enables real-time detection of cancer at the surface of excised tissue specimens during…
Read MoreMarginProbe® Device is Able to Reduce Re-Excision Rate of Breast Conserving Surgery in Invasive and Pre-Invasive Breast Cancer Independent from Any Patient or Tumor Related Factors
[vc_row][vc_column][vc_column_text] San Antonio Breast Cancer Symposium – December 9-13, 2014 Blohmer JU (1,2), Tanko J (2), Groß J (1,2), Völker R (1,2) 1) Chrité Gyn and Breast Dept; Sankt Gertrauden Hosp Gyn and Breast Dept Abstract Background: A positive margin status after breast conserving surgery (BCS) is one of the strongest predictors of local recurrence…
Read MoreCombined Experience at Three Breast Centers with Routine Use of an Intraoperative Margin Assessment Device Including Comparison to Historical Re-Excision Rates
Obtaining clear margins following a lumpectomy surgery for breast cancer is an important factor in the treatment of breast cancer while conserving the breast (BCS). Historically, high rates, 26%, of surgical interventions to obtain clear margins have been reported1 .
Read More